<DOC>
	<DOCNO>NCT03043768</DOCNO>
	<brief_summary>In Parkinson 's disease ( PD ) , alpha-synuclein accumulation cutaneous autonomic pilomotor sudomotor nerve fiber link autonomic nervous system disturbance even early stage disease . The investigator recently introduce non-invasive technique assess autonomic adrenergic fiber function use quantitative pilomotor axon-reflex test ( QPART ) . In present study investigator aim assess association alpha-synuclein mediated structural autonomic nerve fiber damage nerve function PD , elucidate role neuropathy progression early disease stage , test reproducibility external validity pilomotor function assessment use quantitative pilomotor axon-reflex test ( QPART ) sudomotor function via quantitative direct indirect test sudomotor function ( QDIRT ) . A prospective control study conduct four site ( Dresden , Germany ; Berlin , Germany ; Budapest , Hungary ; Boston , USA ) . A total 52 male female patient idiopathic PD ( Hoehn &amp; Yahr 1-2 ) 52 age- sex-matched healthy control recruit . Pilomotor function evaluate iontophoresis phenylephrine dorsal forearm elicit cutaneous axon-reflex mediate response ( goosebump ) . Silicone impression stimulate area obtain , scan quantified pilomotor muscle impression number , impression size area axon-reflex pilomotor erection spread . Sudomotor function evaluate axon-reflex stimulation via iontophoresis acetylcholine dorsal forearm . Stained sweat droplet capture use repeat digital photography quantify time droplet number axon-reflex spread . Sympathetic skin response follow deep inspiration analyze use skin conductance quantification . Testing evaluation autonomic motor symptom perform baseline , 2 week , 1 year , 2 year 3 year . Skin biopsy obtain baseline 3 year analyze nerve fiber density alpha-synuclein accumulation . The investigator expect study unveil whether progression autonomic nerve dysfunction assess via pilomotor sudomotor axon-reflex test related progression autonomic symptom severity alpha-synuclein deposition PD . Additionally , potential application use technique include interventional study evaluate disease-modifying approach clinical assessment autonomic dysfunction patient PD .</brief_summary>
	<brief_title>Cutaneous Autonomic Pilomotor Testing Unveil Role Neuropathy Progression Early Parkinson 's Disease</brief_title>
	<detailed_description>PURPOSE OF THE PROTOCOL With goal develop novel endpoint early stage trial disease modify therapy Parkinson 's disease ( PD ) objective study ) ass reproducibility b ) external validity reliability c ) perform longitudinal assessment sudomotor ( QDIRT ) pilomotor ( QPART ) responses early PD patient . Moreover , study aim assess hypothesis functional impairment pilomotor sudomotor nerve fiber early PD correlate a-synuclein deposition mediate structural fiber damage may therefore constitute potential non- invasive biomarker autonomic involvement PD . BACKGROUND In skin biopsy study PD , alpha-synuclein accumulation cutaneous autonomic nerve fiber link autonomic nervous system disturbance even early stage disease . ( 1 ) The investigator recently introduce non-invasive technique assess autonomic adrenergic fiber function use quantitative pilomotor axon-reflex test ( QPART ) . ( 2 ) OBJECTIVES Demonstrating generalizability reliability QPART technique , anticipate positive result protocol might lend support utility QPART diagnostic tool . This might particular interest clinical practice QPART technique show assess small fiber function low variability comparatively low technical effort whereas vasomotor assessment limited high variability sudomotor assessment require technical demand setting . ( 3 ) Moreover , anticipate positive correlation functional structural pilomotor nerve fiber impairment might support capacity QPART technique ass specific fiber damage thus provide non-invasive tool 1 . ) study pilomotor nerve damage research study 2 . ) allow longitudinal clinical assessment PD patient monitor disease progression . ETHICAL STANDARD The study protocol approve institutional review board Technische Universität Dresden ( IRB study reference : EK349082015 ) well institutional review board participate site ( Berlin accept protocol base Technische Universität Dresden IRB approval ; Budapest IRB number : 004513-004/2016/OTIG ; Boston IRB number : 2016P000141 ) This study conduct accord principle express Declaration Helsinki . Written inform consent obtain study participant . The consent review subject one study physician . The subject sign inform consent procedure pertain study initiate . A copy sign informed consent give participant another copy keep file . Conduction study comply GCP ( Good Clinical Practice ) guideline . STUDY PROCEDURES Quantitative Pilomotor Axon-Reflex Test ( QPART ) : Iontophoresis phenylephrine use induce axon-reflex mediate piloerection . A drug delivery capsule electrode ( LI-611 ; Perimed® , Järfälla , Sweden ) affix test area dorsal forearm . The inner chamber capsule , open skin surface , fill 0.4ml 1 % phenylephrine solution . The drug delivery electrode connect iontophoresis stimulation box ( Phoresor II-Auto-PM850 ; IOMED Inc. , Salt Lake City , USA ) . Iontophoresis perform 1cm diameter skin region 0.5mA 5 minute . Silicone impression piloerection obtain create local topographic map piloerection . A silicone base two-phase material high liquidity ( Honigum Light , DMG , Hamburg , Germany ) place skin 10 second . The silicone cure 5 minute , toner apply mark pilomotor impression , excess toner wipe free silicone scan capture image digitally . Silicone impression erect hair follicle quantify number area spatial spread . A high resolution scanner ( Fuel 3D® Technologies Limited , Chinnor , United Kingdom ) connect personal computer equip image analyze software ( Fuel3D® Studio Starter ; Fuel 3D® Technologies Limited , Chinnor , United Kingdom ) use quantify additionally goosebump reaction . Sympathetic Skin Response ( SSR ) : The skin conductance level ( SCL ) measure µSievert ( µS ) two medial phalanx ( index third finger ) Powerlab® polygraph ( AD Instruments , Bella Vista , Australia ) . The maximum increase amplitude follow sudden deep respiration ( Sympathetic Skin Response ; SSR ) calculate quantify functional reactivity sweat glands previously describe . ( 4 ) Quantitative Direct Indirect Test Sudomotor Function ( QDIRT ) : Axon-reflex mediate sweating measure iontophoresis 10 % acetylcholine drying stimulate region volar aspect forearm dust indicator dye ( povidone-iodine cornstarch ) follow repeated digital photograph take every 15 second 7 minute 18 Megapixel camera ( EOS 60D ; Canon Inc. , Tokyo , Japan ) 100-mm macro lens . Images digitally analyze droplet number , size , axon-reflex spread previously describe . ( 5 ) Evaluation perceive motor autonomic symptom : Progression motor autonomic symptom assess validated symptom score MDS-UPDRS motor part SCOPA AUT . Skin biopsy : a-synuclein/PGP Ratio ; Immunhistochemical stain a-synuclein intraepidermal nerve fiber perform 3 skin punch biopsy obtain QPART test site two control site ( low leg ) . Three-millimeter biopsy obtain follow local anesthesia 2 % lidocaine . Biopsy specimens fix Zamboni solution 18 hour cryoprotected overnight ( 20 % glycerol 20 % 0.4 M Sorensen buffer ) . Skin block cut use freeze microtome 20 tissue section analyze . 20 tissue section analyze . Alpha synuclein/intraepidermal nerve fiber density ratio calculate . TIMELINE Subjects assess eligibility list study physician . At baseline subject undergo medical history , physical examination , QPART , SSR , QDIRT , MDS-UPDRS SCOPA AUT assessment described . These test procedure repeat , 1-2 week , 1 year , 2 year , 3 year post-baseline . All test performed temperature humidity control environment . Only Dresden-Site subject additionally undergo skin punch biopsy procedure describe baseline , 1 year 3 year .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>INCLUSION CRITERIA Male female PD patient ( idiopathic parkinsonism , Hoehn Yahr [ H &amp; Y ] score 12 ) age 35 80 year ageand gender match healthy control subject EXCLUSION CRITERIA dermatological disorder affect cutaneous test region treatment tricyclic antidepressant , noradrenergic antidepressant , betablockers , alphaadrenergic agonist antagonist , cholinergic anticholinergic agent know allergy phenylephrine acetylcholine elevate alcohol consumption ( 4 alcoholic beverages/week ) nicotine consumption within past 5 year know disorder affect autonomic function ( include diabetes , pure autonomic failure , inflammatory demyelinate polyradiculoneuropathies , multiple system atrophy , atypical Parkinson syndrome , body mass index 25 kg/m2 , acute chronic renal disease , gout , rheumatoid arthritis , Lupus , Sjogren 's syndrome , Triple A syndrome , autonomic neuropathy relate PD )</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Autonomic</keyword>
	<keyword>Diagnosis</keyword>
	<keyword>Pilomotor</keyword>
	<keyword>Alpha-synuclein</keyword>
	<keyword>Axon-reflex</keyword>
	<keyword>Peripheral nerve fiber</keyword>
</DOC>